3D radiomic platform for imaging biomarker development
US12217429B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Oct 29, 2021 |
| Grant date | Feb 4, 2025 |
| Priority date | — |
| Expiry date | May 21, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG06T2210/41
- WIPO fieldComputer technology
- WIPO sectorElectrical engineering
Abstract
A platform is provided for generating 3D models of a tumor segmented from a series of 2D medical images and for identifying from these 3D models, radiomic features that may be used for diagnostic, prognostic, and treatment response assessment of the tumor. The radiomic features may be shape-based features, intensity-based features, textural features, and filter-based features. The radiomic features are compared to remove sufficiently redundant features, thereby producing a reduced set of radiomic features, which is then compared to separate genomic data and/or outcome data to identify clinically and biologically significant radiomic features for diagnostic, prognostic, and treatment response assessment, other applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.